Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $824.6700 (1%) ($824.6700 - $827.6200) on Thu. Sep. 7, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.73% (three month average) | RSI | 66 | Latest Price | $824.6700(1%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.2% a day on average for past five trading days. | Weekly Trend | REGN declines -0.3% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) XLV(67%) IBB(61%) DIA(55%) XLF(55%) SDY(51%) | Factors Impacting REGN price | REGN will decline at least -0.865% in a week (0% probabilities). VXX(-45%) VIXM(-41%) TBT(-19%) USO(-18%) GLD(-6%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.865% (StdDev 1.73%) | Hourly BBV | 0.6 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $824.49(0.02%) | 10 Day Moving Average | $827.74(-0.37%) | 20 Day Moving Average | $822.06(0.32%) | To recent high | -2.4% | To recent low | 19.1% | Market Cap | $87.439b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |